NUPATHE INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Business Wire

WILMINGTON, Del.--(BUSINESS WIRE)--

Rigrodsky & Long, P.A.:

  • Do you own shares of NuPathe Inc. (NASDAQ GM: PATH)?
  • Did you purchase any of your shares prior to December 16, 2013?
  • Do you think the proposed buyout price is too low?
  • Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of NuPathe Inc. (“NuPathe” or the “Company”) (NASDAQ GM: PATH) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Endo Health Solutions Inc. (“Endo”) (NASDAQ GS: ENDP), in a transaction valued at approximately $105 million.

Click here to learn more: http://www.rigrodskylong.com/investigations/nupathe-inc-path.

Under the terms of the agreement, public shareholders of NuPathe will receive $2.85 per share in cash for each share of NuPathe they own. In addition to the upfront cash payment, NuPathe shareholders will receive rights to receive additional cash payments of up to $3.15 per share if specified net sales of NuPathe's migraine treatment ZECUITY are achieved over time.

The investigation concerns whether NuPathe’s board of directors failed to adequately shop the Company and obtain the best possible value for NuPathe’s shareholders before entering into an agreement with Endo. According to Yahoo! Finance, at least one analyst has issued a price target for NuPathe stock at $8.00 per share.

If you own the common stock of NuPathe and purchased your shares before December 16, 2013, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530, by telephone at (888) 969-4242; by e-mail to info@rl-legal.com, or at: http://www.rigrodskylong.com/investigations/nupathe-inc-path.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242
(516) 683-3516
Fax: (302) 654-7530
info@rl-legal.com
http://www.rigrodskylong.com

Rates

View Comments (0)